ProCE Banner Activity

Concordance Between Healthcare Providers and Expert Consensus Recommendations in the Management, Monitoring, and Mitigation of Adverse Events Associated with CAR T-Cell Therapy: An Updated Analysis


This poster, presented at SITC 2020, describes updated results of recent CCO analysis of clinical practice trends suggesting continued suboptimal management of toxicities associated with CAR T-cell therapy administration.

Released: November 25, 2020

Expiration: November 24, 2021

No longer available for credit.


Additional Information

Tradd Sanderson
Director of Marketing
Clinical Care Options
Telephone: 855.224.2241